A novel cuproptosis-related gene signature for predicting prognosis in cervical cancer

L Lei, L Tan, L Sui - Frontiers in genetics, 2022 - frontiersin.org
Purpose: Cuproptosis, a form of copper-induced cell death, can be a promising therapeutic
target for refractory cancers. Hence, we conducted this research to explore the association …

Prevalence and distribution of human papillomavirus genotypes among women attending gynecology clinics in northern Henan Province of China

X Wang, Y Song, X Wei, G Wang, R Sun, M Wang… - Virology journal, 2022 - Springer
Background Human papillomavirus (HPV) infection can cause cervical and other cancers,
including vulva, vagina, penis, anus, or oropharynx. However, in China's northern Henan …

Immunotherapy in cervical cancer: From the view of scientometric analysis and clinical trials

Y Xing, F Yasinjan, Y Du, H Geng, Y Zhang… - Frontiers in …, 2023 - frontiersin.org
Background Cervical cancer is the fourth most cancer and the fourth leading cause of cancer-
related deaths in women worldwide. Current treatment for patients with advanced cervical …

Epidemiological trends and risk factors of gynecological cancers: an update

V Keyvani, N Kheradmand, ZN Navaei, S Mollazadeh… - Medical Oncology, 2023 - Springer
Gynecological cancers, the most common cancer among women worldwide, disrupt the
function of women's reproductive system, significantly impacting the quality of life. The …

Circular RNA circACAP2 Suppresses Ferroptosis of Cervical Cancer during Malignant Progression by miR‐193a‐5p/GPX4

Y Liu, L Li, Z Yang, D Wen, Z Hu - Journal of oncology, 2022 - Wiley Online Library
Cervical cancer is among the most cancer types, with an extremely high global incidence
and mortality. Ferroptosis is a newly reported programmed cell death process that differs …

[HTML][HTML] Manipulating TGF-β signaling to optimize immunotherapy for cervical cancer

S Yin, H Cui, S Qin, S Yu - Biomedicine & Pharmacotherapy, 2023 - Elsevier
Cervical cancer is a serious threat to women's health globally. Therefore, identifying key
molecules associated with cervical cancer progression is essential for drug development …

Race and ethnicity representation in clinical trials: findings from a literature review of Phase I oncology trials

DR Camidge, H Park, KE Smoyer, I Jacobs… - Future …, 2021 - Taylor & Francis
Aim: To provide an assessment of published literature on the demographic representation in
Phase I trials of biopharmaceutical oncology agents. Materials & methods: We conducted a …

Therapeutic effects of natural products on cervical cancer: based on inflammatory pathways

ZW Zhou, HZ Long, SG Xu, FJ Li, Y Cheng… - Frontiers in …, 2022 - frontiersin.org
Inflammation is a protective response of the body to an irritant. When an inflammatory
response occurs, immune cells are recruited to the injury, eliminating the irritation. The …

[HTML][HTML] Advances in epigenetic modifications and cervical cancer research

H Liu, H Ma, Y Li, H Zhao - Biochimica et Biophysica Acta (BBA)-Reviews …, 2023 - Elsevier
Cervical cancer (CC) is an important public health problem for women, and perspectives
and information regarding its prevention and treatment are quickly evolving. Human …

T cell immunotherapy for cervical cancer: challenges and opportunities

L Yu, G Lanqing, Z Huang, X Xin, L Minglin… - Frontiers in …, 2023 - frontiersin.org
Cancer cellular immunotherapy has made inspiring therapeutic effects in clinical practices,
which brings new hope for the cure of cervical cancer. CD8+ T cells are the effective …